2 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Optic Nerve Injuries: new trials by email Literature Review of Optic Nerve Injuries trials Research Report on Optic Nerve Injuries
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Traumatic Optic Neuropathy Treatment Trial (TONTT) Recombinant human erythropoietin (EPO), Observation, Methyl prednisolone - Traumatic Optic Neuropathy | Phase 1 / Phase 2 | Completed | Tehran University of Medical Sciences | 117 | 2015-02-01 | 2019-05-07 |
| Safety and Efficacy Study of RPh201 Treatment of Ischemic Optic Neuropathy (ION). RPh201, Placebo - Non-arteritic Ischemic Optic Neuropathy, Optic Nerve Injuries | Phase 2 | Completed | Regenera Pharma Ltd | 22 | 2014-02-01 | 2020-03-19 |
Optic Neuropathy, Ischemic (1)
Cranial Nerve Diseases (2) · Cranial Nerve Injuries (2) · Craniocerebral Trauma (2) · Eye Diseases (2) · Nervous System Diseases (2) · Optic Nerve Diseases (2) · Trauma, Nervous System (2) · Wounds and Injuries (2) · Cardiovascular Diseases (1) · Vascular Diseases (1)
Methylprednisolone Acetate (1) · Observation (1)
Regenera Pharma Ltd (1) · Tehran University of Medical Sciences (1)
Iran (1) · Israel (1)
Mohsen B Kashkouli, MD (1) · Zvi Segal,, MD (1)